Avanos Medical (AVNS) News Today → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free AVNS Stock Alerts $20.03 -0.06 (-0.30%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 7:15 AM | prnewswire.comAvanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply ChainMay 11, 2024 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Stock Rating Upgraded by StockNews.comMay 8, 2024 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Given "Market Perform" Rating at JMP SecuritiesMay 7, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Rating Reiterated by JMP SecuritiesJMP Securities reissued a "market perform" rating on shares of Avanos Medical in a research note on Tuesday.May 6, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call TranscriptMay 6, 2024 | americanbankingnews.comAvanos Medical (NYSE:AVNS) Downgraded by StockNews.comMay 3, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Cut to "Hold" at StockNews.comStockNews.com downgraded shares of Avanos Medical from a "buy" rating to a "hold" rating in a research report on Friday.May 3, 2024 | finance.yahoo.comAvanos Medical First Quarter 2024 Earnings: EPS: US$0.011 (vs US$0.17 loss in 1Q 2023)May 3, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Updates FY 2024 Earnings GuidanceAvanos Medical (NYSE:AVNS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 1.300-1.450 for the period, compared to the consensus estimate of 1.380. The company also issued revenue guidance of $685.0 millionillion-$705.0 millionillion, compared to the consensus estimate of $691.0 millionillion.May 3, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 2, 2024 | msn.comAVNS Stock Earnings: Avanos Medical Misses EPS, Beats Revenue for Q1 2024May 2, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses Revenue EstimatesMay 2, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Updates FY24 Earnings GuidanceAvanos Medical (NYSE:AVNS) updated its FY24 earnings guidance. The company provided EPS guidance of $1.30-1.45 for the period, compared to the consensus estimate of $1.38. The company also issued revenue guidance of $685-705 millionillion, compared to the consensus estimate of $691.07 millionillion.May 2, 2024 | sfgate.comAvanos Medical: Q1 Earnings SnapshotMay 2, 2024 | prnewswire.comAvanos Medical, Inc. Announces First Quarter 2024 ResultsMay 1, 2024 | msn.comAvanos Medical Q1 2024 Earnings PreviewApril 26, 2024 | marketbeat.comAvanos Medical (AVNS) Set to Announce Earnings on ThursdayAvanos Medical (NYSE:AVNS) will be releasing earnings on Thursday, May 2, Yahoo Finance reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=589745)April 25, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial ResultsApril 21, 2024 | marketbeat.comFoundry Partners LLC Acquires 158,473 Shares of Avanos Medical, Inc. (NYSE:AVNS)Foundry Partners LLC increased its holdings in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 74.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 371,029 shares of the company's stock after buying an additionalApril 19, 2024 | marketbeat.comKestrel Investment Management Corp Takes Position in Avanos Medical, Inc. (NYSE:AVNS)Kestrel Investment Management Corp purchased a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 145,550 shares of the company's stocApril 19, 2024 | finance.yahoo.comHere's Why Shareholders May Want To Be Cautious With Increasing Avanos Medical, Inc.'s (NYSE:AVNS) CEO Pay PacketApril 2, 2024 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) Short Interest UpdateAvanos Medical, Inc. (NYSE:AVNS - Get Free Report) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,340,000 shares, an increase of 6.3% from the February 29th total of 1,260,000 shares. Based on an average daily volume of 297,300 shares, the days-to-cover ratio is currently 4.5 days. Approximately 3.0% of the company's stock are sold short.March 16, 2024 | insidertrades.comAvanos Medical, Inc. (NYSE:AVNS) CFO Michael Greiner Sells 8,000 SharesMarch 15, 2024 | marketbeat.comInsider Selling: Avanos Medical, Inc. (NYSE:AVNS) CFO Sells 8,000 Shares of StockAvanos Medical, Inc. (NYSE:AVNS - Get Free Report) CFO Michael Greiner sold 8,000 shares of the firm's stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $19.12, for a total value of $152,960.00. Following the sale, the chief financial officer now owns 151,495 shares of the company's stock, valued at $2,896,584.40. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.March 11, 2024 | marketbeat.comZacks Research Comments on Avanos Medical, Inc.'s Q2 2024 Earnings (NYSE:AVNS)Avanos Medical, Inc. (NYSE:AVNS - Free Report) - Zacks Research reduced their Q2 2024 EPS estimates for shares of Avanos Medical in a research report issued to clients and investors on Thursday, March 7th. Zacks Research analyst D. Dey now anticipates that the company will post earnings per shareFebruary 29, 2024 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. lifted its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 6.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 570,442 shares of the coFebruary 23, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Issues FY 2024 Earnings GuidanceAvanos Medical (NYSE:AVNS) updated its FY 2024 earnings guidance. The company provided EPS guidance of 1.300-1.450 for the period.February 22, 2024 | finance.yahoo.comAvanos Medical Full Year 2023 Earnings: US$0.21 loss per share (vs US$1.08 profit in FY 2022)February 22, 2024 | markets.businessinsider.comAvanos Medical Issues Voluntary Recall Amid Nurse Assist Sterile Water Product RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | prnewswire.comAvanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products RecallFebruary 21, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call TranscriptFebruary 21, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Announces Earnings ResultsAvanos Medical (NYSE:AVNS - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.36 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.01). The business had revenue of $173.30 million for the quarter, compared to analysts' expectations of $170.43 million. Avanos Medical had a positive return on equity of 5.22% and a negative net margin of 7.39%. The firm's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.60 EPS.February 20, 2024 | msn.comSupplementary Review: Avanos Medical (AVNS), February 20, 2024February 20, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Shares Gap Down to $19.19Avanos Medical (NYSE:AVNS) Shares Gap Down to $19.19February 20, 2024 | seekingalpha.comAvanos Medical, Inc. 2023 Q4 - Results - Earnings Call PresentationFebruary 20, 2024 | msn.comAvanos Medical reports mixed Q4 results; initiates FY24 outlookFebruary 20, 2024 | finance.yahoo.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsFebruary 20, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Reports Mixed 2023 Financial Results Amid Transformation InitiativeFebruary 20, 2024 | marketbeat.comAvanos Medical (NYSE:AVNS) Issues FY24 Earnings GuidanceAvanos Medical (NYSE:AVNS) updated its FY24 earnings guidance. The company provided EPS guidance of $1.30-1.45 for the period, compared to the consensus estimate of $1.38. The company also issued revenue guidance of $685-705 millionillion, compared to the consensus estimate of $690.00 millionillion.February 20, 2024 | prnewswire.comAvanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 ResultsFebruary 17, 2024 | finance.yahoo.comAVNS Mar 2024 20.000 callFebruary 16, 2024 | msn.comAvanos Medical Q4 2023 Earnings PreviewFebruary 16, 2024 | marketbeat.comWilliam Blair Investment Management LLC Purchases New Position in Avanos Medical, Inc. (NYSE:AVNS)William Blair Investment Management LLC acquired a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,094,675 sharesFebruary 15, 2024 | finance.yahoo.comAvanos Medical, Inc. (AVNS)February 14, 2024 | markets.businessinsider.comAnalysts Are Neutral on These Healthcare Stocks: Avanos Medical (AVNS), Incyte (INCY)February 14, 2024 | marketbeat.comAvanos Medical (AVNS) Scheduled to Post Quarterly Earnings on TuesdayAvanos Medical (NYSE:AVNS) will be releasing earnings before the market opens on Tuesday, February 20, Zacks reports.February 14, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial ResultsFebruary 13, 2024 | marketbeat.comFoundry Partners LLC Acquires 39,068 Shares of Avanos Medical, Inc. (NYSE:AVNS)Foundry Partners LLC increased its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 22.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 212,556 shares of the company's stock after buying an additional 39February 11, 2024 | marketbeat.comAvanos Medical, Inc. (NYSE:AVNS) Shares Purchased by Jupiter Asset Management Ltd.Jupiter Asset Management Ltd. grew its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 234.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 149,983 shares of the company's stock after b Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Email Address Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company. Discover why this company AVNS Media Mentions By Week AVNS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVNS News Sentiment▼0.400.55▲Average Medical News Sentiment AVNS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVNS Articles This Week▼32▲AVNS Articles Average Week Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Jin Medical International News Today Sanara MedTech News Today Establishment Labs News Today Enovis News Today Centessa Pharmaceuticals News Today OPKO Health News Today USANA Health Sciences News Today Liquidia News Today 89bio News Today Viridian Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AVNS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
